U.S., April 15 -- ClinicalTrials.gov registry received information related to the study (NCT07529912) titled 'Detecting Beta-amyloid in the Retina' on April 08.
Brief Summary: Hyperspectral retinal imaging is a non-invasive imaging modality in which a series of images of the retina are captured using light of different wavelengths. The resulting "hypercube" of data provides a wealth of information about the retinal structure. Our group has developed evidence supporting a role for this technology in the detection of retinal amyloid beta in Alzheimer's disease. We are undertaking further studies to establish the role of this method in the assessment of people with dementia, or those at risk of Alzheimer's disease.
Study Start Date: Feb. 04,...